Enanta Pharmaceuticals Inc (ENTA)
9.30
+0.22
(+2.42%)
USD |
NASDAQ |
Nov 21, 15:26
Enanta Pharmaceuticals Price: 9.30 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 9.34 | 9.39 | 8.980 | 9.08 | 158736.0 |
| Nov 19, 2024 | 9.40 | 9.60 | 9.22 | 9.42 | 95602.00 |
| Nov 18, 2024 | 9.52 | 9.65 | 9.36 | 9.57 | 177566.0 |
| Nov 15, 2024 | 10.24 | 10.24 | 9.522 | 9.53 | 157704.0 |
| Nov 14, 2024 | 10.46 | 10.88 | 10.09 | 10.13 | 86506.00 |
| Nov 13, 2024 | 10.84 | 10.85 | 10.31 | 10.43 | 116721.0 |
| Nov 12, 2024 | 10.82 | 11.00 | 10.57 | 10.66 | 130996.0 |
| Nov 11, 2024 | 11.11 | 11.19 | 10.70 | 10.87 | 100762.0 |
| Nov 08, 2024 | 11.27 | 11.31 | 11.00 | 11.07 | 63976.00 |
| Nov 07, 2024 | 11.56 | 11.57 | 11.35 | 11.35 | 62604.00 |
| Nov 06, 2024 | 11.80 | 11.83 | 11.08 | 11.52 | 144814.0 |
| Nov 05, 2024 | 11.12 | 11.40 | 10.99 | 11.26 | 74756.00 |
| Nov 04, 2024 | 10.92 | 11.35 | 10.84 | 11.11 | 89896.00 |
| Nov 01, 2024 | 11.32 | 11.39 | 10.93 | 10.95 | 100080.0 |
| Oct 31, 2024 | 11.51 | 11.57 | 10.71 | 11.24 | 89278.00 |
| Oct 30, 2024 | 11.49 | 11.68 | 11.28 | 11.49 | 119398.0 |
| Oct 29, 2024 | 11.51 | 11.58 | 11.26 | 11.50 | 114356.0 |
| Oct 28, 2024 | 11.78 | 12.09 | 11.52 | 11.58 | 93747.00 |
| Oct 25, 2024 | 12.15 | 12.26 | 11.64 | 11.68 | 110348.0 |
| Oct 24, 2024 | 12.73 | 12.81 | 12.09 | 12.15 | 147315.0 |
| Oct 23, 2024 | 12.96 | 13.37 | 12.25 | 12.75 | 210415.0 |
| Oct 22, 2024 | 12.58 | 13.13 | 12.46 | 13.00 | 136913.0 |
| Oct 21, 2024 | 12.59 | 12.88 | 12.40 | 12.64 | 162493.0 |
| Oct 18, 2024 | 12.26 | 12.70 | 12.19 | 12.63 | 98218.00 |
| Oct 17, 2024 | 12.09 | 12.29 | 11.87 | 12.28 | 66405.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
8.18
Minimum
Nov 13 2023
97.37
Maximum
Nov 05 2021
41.17
Average
46.67
Median
Jan 13 2021
Price Benchmarks
| NovaBay Pharmaceuticals Inc | 0.681 |
| Palatin Technologies Inc | 0.9146 |
| iBio Inc | 2.40 |
| Theriva Biologics Inc | 1.24 |
| Oragenics Inc | 0.27 |
Price Related Metrics
| PS Ratio | 2.730 |
| Price to Book Value | 1.323 |
| Earnings Yield | -58.60% |
| Market Cap | 197.05M |